Author: Jim Potter

CHC_general1

FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions

CHC-offLabel2

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

hhs NEWS

HHS Formally Withdraws SUNSET Final Rule

CDER.Slide

OPDP Reorg, Outreach Efforts Designed to Improve Relationship with Industry

CHC_general2

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

CDER.News

Only 6 Percent of Novel Drug Approvals in 2021 Involved Advisory Committee Meetings

CHC_Legislative1

User Fee Legislation Markup Suggests Added FDA Regulatory Authorities

CHC-offLabel2

Clinical Trials Not Sufficiently Diverse – and Diversity Data Often Not Reported

HHSOIGNews

Medicare Advantage Plans May Promise More but Deliver Less